Wilmington Healthcare appoints new Head of Digital
January 26, 2021 |
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.
In his new role, Mikko will develop and drive the strategy and execution of our clients’ intelligence-led and data-driven omni-channel programmes. These combine multiple channels, including OnMedica – an online community providing bitesize, evidence-based Continuing Professional Development (CPD) and other content for GPs and specialist doctors.
Mikko joins Wilmington Healthcare from the Brain Tumour Charity where, as Head of Digital, he led a team responsible for delivering digital marketing and communications plans across the organisation for income generation and to support service delivery.
Prior to that, he was UK Digital Marketing Manager for Pfizer, where he developed the digital strategy for its UK Rare Diseases Business Unit, which became one of the company’s most successful digital engagement ventures, with initiatives such as patient mobile apps, interactive digital detail aids for sales representatives, and a series of multichannel marketing campaigns.
He also led a team of cross functional stakeholders and external agencies to deliver a consumer-facing multichannel awareness campaign for a rare disease, winning a Pfizer global innovation award in the process.
Mikko has also held roles in digital marketing, customer acquisition, and supporter retention at organisations across a range of industries, including publishing, politics, and B2B service delivery.
Simon Grime, of Wilmington Healthcare, says: “We’re delighted to have Mikko on the team and, having worked in both the pharma and healthcare charity sectors, he brings a really valuable blend of digital marketing experience to his new post.
“He will be a fantastic addition to the company, where he will play a key role in shaping our intelligence-led omni-channel marketing strategy and helping our clients deliver the optimal mix of channels to complement their customer engagement strategies.”
Ends
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
A new vision for tackling key illnesses
Steve How and Oli Hudson, of Wilmington Healthcare, explore the NHS Long-term Plan’s strategy for delivering more preventative, joined-up services for major health conditions
Spotlight on innovation at life sciences forum
Paul Midgley, of Wilmington Healthcare, takes a look at the forthcoming HSJ Life Sciences Forum, where the NHS and industry will unite to discuss challenges and explore innovative solutions
GPs will play a pivotal role in integrated care
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explain how the new GP contract will shape local joined-up systems
What role for pharma in helping to deliver integrated care?
Steve How and Paul Midgley, of Wilmington Healthcare, explore how pharma can support local health economies in providing joined-up, holistic services
Winners of the HSJ Partnership Awards 2019 unveiled
The winners of the HSJ Partnership Awards 2019 were announced on 20 March at a prestigious black-tie awards ceremony at Park Plaza, Westminster.
Putting disease prevention on a par with cure
Steve How and Paul Midgley, of the Wilmington Healthcare Consulting Team, explore how the NHS is taking an increasingly holistic approach to care
What does the new NHS plan mean for pharma?
Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of the NHS Long-term Plan
HSJ Partnership Awards 2019 shortlist announced
The finalists for the HSJ Partnership Awards have been announced today ahead of a prestigious black-tie dinner awards ceremony at Park Plaza, Westminster Bridge on 20 March 2019.
Healthcare excellence celebrated at 2018 HSJ Awards
Thousands of healthcare professionals were in attendance, all eager to scoop one of the coveted prizes from the world’s largest healthcare awards programme.
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry